George Tetz has a total of 87 co-authors. Here are the top co-authors by number of shared publications:

  • Victor Tetz

    Human Microbiology Institute, New York, New York, USA

    41 shared publications
  • Victor Tetz

    Department of Structural Biology, Human Microbiology Instititue, New York, NY, United States

    27 shared publications
  • Maria Vecherkovskaya

    Department of Structural Biology, Human Microbiology Instititue, New York, NY, United States

    10 shared publications
  • Kristina Kardava

    Department of Structural Biology, Human Microbiology Instititue, New York, NY, United States

    9 shared publications
  • Alireza Khodadadi-Jamayran

    Applied Bioinformatics Laboratories, Division of Advanced Research Technologies, New York University (NYU) School of Medicine, New York, NY, United States

    8 shared publications
  • Aristotelis Tsirigos

    Department of Pathology, New York University Grossman School of Medicine, New York, USA

    7 shared publications

Latest Publications

  • Open Access

    Why Does Immortality Not Exist, and Can It Be Achieved?

    by Victor Tetz, George Tetz

    In this work, we analyze the reasons for the absence of immortality from the perspective of “genetic information metabolism.” All living organisms synthesize and release genes, including novel and previously unknown genes, into the external environment through the process of genetic information metabolism. As a result, new genes become available for inclusion in the unified complex of genetic information represented by all living and non-living carriers, which has been termed the “Pangenome,” ensuring the maintenance of life on Earth under changing biotic and abiotic conditions. Part of the newly created genetic information remains inaccessible to spreading to other members of the Pangenome during the lifetime of an organism and can only be released after its death. We hypothesize, to our knowledge for the first time, that the absence of immortality is associated with the necessity of releasing novel genes for spread within the Pangenome, which can happen efficiently only after an organism’s death. We define the spread of genes and their integration into the genomes of other organisms as “gene reincarnation.” Within the Pangenome, genes are redistributed, ensuring the further evolution of life. We formulate a new definition of death as “a stage in the metabolism of genetic information during which all genes of an organism become available for reincarnation.” This understanding for the first time views death as a crucial part of the genetic cycle of life. Based on above novel concepts, we propose certain properties that immortal organisms should possess.

  • Open Access

    Partial response in a patient with skeletal and hepatic metastases following resected pancreatic cancer to the novel cell therapy SL-28: a case report

    by Victor Tetz, Kristina Kardava, Olzhas Shulenbayev, Maria Vecherkovskaya, Alireza Khodadadi-Jamayran, Aristotelis Tsirigos, George Tetz

    Pancreatic cancer is a deadly and highly metastatic malignancy; the liver is the most frequent site of metastasis (70-80%), however, bone metastases are rare, occurring in approximately 5% of cases. Currently, there are no documented reports of effective responses to therapy for bone metastases, especially in the context of cell-based treatments. Here, we report the first case of a partial response according to RECIST v1.1, with a reduction in size and dissolution of liver and bone metastases from pancreatic cancer, for the novel cell therapy, SL-28, under the expanded access pathway (NCT06872489). SL-28 (Leukocyte-Tells) is a novel cell therapy that uses allogeneic leukocytes, whose anticancer activity is increased ex vivo using the recently discovered Universal Receptive System. A 79-year-old female, staged T4N0M1 after distal pancreatectomy with splenectomy, developed liver and bone metastases that were unresponsive to chemotherapy. A partial response was achieved in the third month of monotherapy SL-28 with partial disappearance of the metastasis in the right femur and a reduction in the metastatic bone mass in the left pubic bone, with over a 30% decrease in the sum of the diameters of the target lesions. In the liver, some metastatic lesions disappeared along with a shrinkage in the size of others. SL-28 therapy was well tolerated with no serious adverse effects. This is the first clinical case describing the partial response of a patient with liver and bone metastases after resection of pancreatic cancer to cell therapy using a novel type of cell therapy with SL-28.

  • Open Access

    Susceptibility and resistance of Gram-negative bacteria to a novel antimicrobial agent TGV-49

    by Victor V. Tetz, Kristina M. Kardava, Maria F. Vecherkovskaya, Semen A. Leyn, Marinela L. Elane, Andrei L. Osterman, George V. Tetz

    Introduction: Antimicrobial resistance remains a major global public health challenge that necessitates novel drugs with a low resistance rate. Methods: Herein, we evaluate TGV-49, a novel broad-spectrum antimicrobial agent, against multidrug-resistant Gram-negative bacteria, including ESKAPE pathogens ( Acinetobacter baumannii , Pseudomonas aeruginosa , and Klebsiella pneumoniae ) and pathogens from agriculture that infect humans ( Ralstonia solanacearum and Aeromonas hydrophila ). Results: TGV-49 was highly effective in overcoming resistance to conventional antibiotics. The experimental evolution of A. baumannii using a morbidostat revealed minimal development of resistance. Conclusion: Our findings suggest TGV-49 as a potential alternative for combating MDR infections in clinical and agricultural settings.

  • Open Access

    Regulating white blood cell activity through the novel universal receptive system

    by Victor Tetz, Kristina Kardava, Maria Vecherkovskaya, Alireza Khodadadi-Jamayran, Aristotelis Tsirigos, George Tetz

    The understanding of the mechanisms that control key features of immune cells in various disease contexts remains limited, and few techniques are available for manipulating immune cells. Thus, discovering novel strategies for regulating immune cells is essential for gaining insight into their roles in health and disease. In this study, we investigated the potential of the recently described Universal Receptive System to regulate human immune cell functions. This was achieved for the first time by specifically targeting newly discovered surface-bound DNA- and RNA-based receptors on leukocytes using endonucleases and generating “Leukocyte-Tells.” Using this approach, 1,496 genes were upregulated, many of which are related to immune cell signaling, migration, endocytosis, and phagocytosis pathways. The antimicrobial and anticancer activities of Leukocyte-Tells exceeded those of control leukocytes in vitro. Under some conditions, such as in antibiofilm experiments against biofilms of Staphylococcus spp., Pseudomonas spp, Candida spp., and other microorganisms, Leukocyte-Tells showed up to 1,000,000-fold higher activities than did control leukocytes. Additionally, Leukocyte-Tells exhibited significantly higher levels of TNF, IL-1β, IFN-γ, IL-6, and IL-10 production. Our findings reveal, for the first time, that the Universal Receptive System can orchestrate fundamental properties of immune cells, including enhanced antimicrobial and anti-tumor activities. This novel approach offers a new avenue for understanding the biology and regulation of white blood cells. Regulation of leucocyte activity is crucial for a properly functioning immune response and developing novel cell-based therapies. Our previous findings demonstrated the existence of nucleic acid-based receptors (Teazeled receptors, TezRs) that govern the responses of various cell types to a diverse array of environmental factors. Here, we discovered that by modulating these TezRs, we could upregulate immune cell signaling, migration, endocytosis, and phagocytosis pathways in leukocytes. By leveraging TezRs, we generated Leukocyte-Tells, which exhibited significantly higher antimicrobial and anticancer activities than the original immune cells.


  • Open Access

    The universal receptive system: a novel regulator of antimicrobial and anticancer compound production by white blood cells

    by Victor Tetz, Kristina Kardava, Maria Vecherkovskaya, Alireza Khodadadi-Jamayran, Aristotelis Tsirigos, George Tetz

    Despite recent advances, the regulation of anticancer and antimicrobial bioactive compound (AABC) production by leukocytes remains poorly understood. Here, we demonstrate that inactivation of the DNA- and RNA-based Teazeled receptors of the Universal Receptive System in human leukocytes generated so called “Leukocyte-Tells,” which showed enhanced AABC production. Comprehensive analysis of the AABCs produced by Leukocyte-Tells based on LC/MS identified 707 unique or differentially produced peptide or nonpeptide metabolites. Functional testing demonstrated that many of these metabolites exhibited increased antibacterial, antifungal, and anticancer activities. The AABCs produced by the Leukocyte-Tells were effective against different multidrug-resistant clinical isolates of fungi and gram-positive and gram-negative bacteria (including their biofilms), as well as various cancer cell lines, with >100,000-fold activity than AABCs derived from control leukocytes. Notably, the AABCs produced by the Leukocyte-Tells exhibited greater stability under adverse environmental conditions. Our findings highlight the important role of the Universal Receptive System in regulating AABC production through a process named here as cell genome-memory management, offering new insights into immune functions and suggesting potential therapeutic applications.


  • Open Access

    Regulating white blood cell activity through the novel Universal Receptive System

    by Victor Tetz, Kristina Kardava, Maria Vecherkovskaya, Alireza Khodadadi-Jamayran, Aristotelis Tsirigos, George Tetz

    The understanding of the mechanisms that control key features of immune cells in various disease contexts remains limited, and few techniques are available for manipulating immune cells. Thus, discovering novel strategies for regulating immune cells is essential for gaining insight into their roles in health and disease. In this study, we investigated the potential of the recently described Universal Receptive System to regulate human immune cell functions. This was achieved for the first time by specifically targeting newly discovered surface-bound DNA and RNA-based receptors on leukocytes and generating “Leukocyte-Tells.” This approach upregulated numerous genes related to immune cell signaling, migration, endocytosis, and phagocytosis pathways. The antimicrobial and anticancer activities of Leukocyte-Tells exceeded the activity of control leukocytes in vitro . In some settings, such as in antibiofilm experiments, the Leukocyte-Tells showed up to 1,000,000-fold higher activities than control leukocytes. Our findings reveal, for the first time, that the Universal Receptive System can orchestrate fundamental properties of immune cells, including enhanced antimicrobial and anti-tumor activities. This novel approach offers a new avenue for understanding the biology and regulation of white blood cells.


  • Open Access

    Universal receptive system as a novel regulator of transcriptomic activity of Staphylococcus aureus

    by George Tetz, Kristina Kardava, Maria Vecherkovskaya, Alireza Khodadadi-Jamayran, Aristotelis Tsirigos, Victor Tetz

    Our previous studies revealed the existence of a Universal Receptive System that regulates interactions between cells and their environment. This system is composed of DNA- and RNA-based Teazeled receptors (TezRs) found on the surface of prokaryotic and eukaryotic cells, as well as integrases and recombinases. In the current study, we aimed to provide further insight into the regulatory role of TezR and its loss in Staphylococcus aureus gene transcription. To this end, transcriptomic analysis of S. aureus MSSA VT209 was performed following the destruction of TezRs. Bacterial RNA samples were extracted from nuclease-treated and untreated S. aureus MSSA VT209. After destruction of the DNA-based-, RNA-, or combined DNA- and RNA-based TezRs of S. aureus, 103, 150, and 93 genes were significantly differently expressed, respectively. The analysis revealed differential clustering of gene expression following the loss of different TezRs, highlighting individual cellular responses following the loss of DNA- and RNA-based TezRs. KEGG pathway gene enrichment analysis revealed that the most upregulated pathways following TezR inactivation included those related to energy metabolism, cell wall metabolism, and secretion systems. Some of the genetic pathways were related to the inhibition of biofilm formation and increased antibiotic resistance, and we confirmed this at the phenotypic level using in vitro studies. The results of this study add another line of evidence that the Universal Receptive System plays an important role in cell regulation, including cell responses to the environmental factors of clinically important pathogens, and that nucleic acid-based TezRs are functionally active parts of the extrabiome.


  • Open Access

    The Universal Receptive System acts as a novel regulator in the production of antimicrobial and anticancer bioactive compounds by white blood cells

    by Victor Tetz, Kristina Kardava, Maria Vecherkovskaya, Alireza Khodadadi-Jamayran, Aristotelis Tsirigos, George Tetz

    Despite recent advances, the regulation of anticancer and antimicrobial bioactive compound (AABC) production by leukocytes remains poorly understood. Here, we demonstrate that inactivation of the DNA- and RNA-based Teazeled receptors of the Universal Receptive System in human leukocytes generated so called “Leukocyte-Tells,” which showed enhanced AABC production. Comprehensive analysis of the AABCs produced by Leukocyte-Tells based on LC/MS identified 707 unique or differentially produced peptide or non-peptide metabolites. Functional testing demonstrated that many of these metabolites exhibited increased antibacterial, antifungal, and anticancer activities. The AABCs produced by the Leukocyte-Tells were effective against different multidrug-resistant clinical isolates of fungi and gram-positive and gram-negative bacteria (including their biofilms), as well as various cancer cell lines, with >100,000-fold activity than AABCs derived from control leukocytes. Notably, the AABCs produced by the Leukocyte-Tells exhibited greater stability under adverse environmental conditions. Our findings highlight the important role of the Universal Receptive System in regulating AABC production through a process named here as cell genome memory management, offering new insights into immune functions and suggesting potential therapeutic applications. Summary The Universal Receptive System acts as a novel regulator of biosynthetic activity in leukocytes. Modulating the leukocyte Universal Receptive System by inactivating Teazeled receptors triggers the production of new compounds not observed in naïve cells. We refer to these TezR-modified cells as “Leukocyte-Tells.” Leukocytes produce unique metabolites with strong anticancer and antimicrobial activities. Reproducibility in generating leukocytes from the blood of different donors suggests that the observed alterations in cell activity were preprogrammed.


  • Open Access

    Universal Receptive System as a novel regulator of transcriptomic activity of Staphylococcus aureus

    by George Tetz, Kristina Kardava, Maria Vecherkovskaya, Alireza Khodadadi-Jamayran, Aristotelis Tsirigos, Victor Tetz

    Our previous studies revealed the existence of a Universal Receptive System that regulates interactions between cells and their environment. This system is composed of DNA- and RNA-based Teazeled receptors (TezRs) found on the surface of prokaryotic and eukaryotic cells, as well as integrases and recombinases.. In the current study, we aimed to provide further insight into the regulatory role of TezR and its loss in Staphylococcus aureus gene transcription. To this end, transcriptomic analysis of S. aureus MSSA VT209 was performed following the destruction of TezRs. Bacterial RNA samples were extracted from nuclease-treated and untreated S. aureus MSSA VT209. After destruction of the DNA-based-, RNA-, or combined DNA- and RNA-based TezRs of S. aureus , 103, 150, and 93 genes were significantly differently expressed, respectively. The analysis revealed differential clustering of gene expression following the loss of different TezRs, highlighting individual cellular responses following the loss of DNA- and RNA-based TezRs. KEGG pathway gene enrichment analysis revealed that the most upregulated pathways following TezR inactivation included those related to energy metabolism, cell wall metabolism, and secretion systems. Some of the genetic pathways were related to the inhibition of biofilm formation and increased antibiotic resistance, and we confirmed this at the phenotypic level using in vitro studies. The results of this study add another line of evidence that the Universal Receptive System plays an important role in cell regulation, including cell responses to the environmental factors of clinically important pathogens, and that nucleic acid-based TezRs are functionally active parts of the extrabiome.


  • Open Access

    AAV ‐mouse DNase I sustains long‐term DNase I expression in vivo and suppresses breast cancer metastasis

    by Melanie Herre, Kalyani Vemuri, Jessica Cedervall, Stefanie Nissl, Falk Saupe, Jacob Micallef, Henrik Lindman, Casey A. Maguire, George Tetz, Victor Tetz, et al.

    Neutrophil extracellular traps (NETs) have been implicated in the pathology of various inflammatory conditions. In cancer, NETs have been demonstrated to induce systemic inflammation, impair peripheral vessel and organ function and promote metastasis. Here we show that the plasma level of NETs is significantly higher in patients with metastatic breast cancer compared to those with local disease, or those that were considered cured at a 5‐year follow‐up, confirming NETs as interesting therapeutic targets in metastatic breast cancer. Administration of DNase I is one strategy to eliminate NETs but long‐term treatment requires repeated injections and species‐specific versions of the enzyme. To enhance administration and therapeutic efficacy, we have developed an adeno‐associated virus (AAV) vector system for delivery of murine DNase I and addressed its potential to counteract cancer‐associated pathology in the murine MMTV‐PyMT model for metastatic mammary carcinoma. The AAV vector is comprised of capsid KP1 and an expression cassette encoding hyperactive murine DNase I (AAV‐mDNase I) under the control of a liver‐specific promotor. This AAV‐mDNase I vector could support elevated expression and serum activity of murine DNase I over at least 8 months. Neutrophil Gelatinase‐Associated Lipocalin (NGAL), a biomarker for kidney hypoperfusion that is upregulated in urine from MMTV‐PyMT mice, was suppressed in mice receiving AAV‐mDNase I compared to an AAV‐null control group. Furthermore, the proportion of mice that developed lung metastasis was reduced in the AAV‐mDNase I group. Altogether, our data indicate that AAV‐mDNase I has the potential to reduce cancer‐associated impairment of renal function and development of metastasis. We conclude that AAV‐mDNase I could represent a promising therapeutic strategy in metastatic breast cancer.